Specialty Pharmacy

Infectious disease and HIV specialists may be more willing to prescribe HIV preexposure prophylaxis than primary care providers.

Top news of the week from Specialty Pharmacy Times.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Despite the benefits of oral oncolytics, high out-of-pocket costs could put treatment out of reach for patients with cancer.

A small number of liquid biopsy test results from different providers matched for overlapping genetic sequences.

Treatment with upadacitinib resulted in reduced disease activity and clinical remission in patients with rheumatoid arthritis.

Providing information about breast cancer surgery via an online tool may help patients feel more informed about their treatment options.

Top news of the day from across the health care landscape.

Promacta is a bone marrow stimulant previously approved by the FDA to treat adults and children with chronic immune thrombocytopenia.

Daratumumab combination therapy tripled the minimal residual disease negativity rate among patients with multiple myeloma.

The Maraba virus was observed to kill latently infected HIV cells.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses how patient data can be used to drive down drug costs.

Top news of the day from across the health care landscape.

The Centers for Medicare and Medicaid Services finalized a ruling that slashes reimbursement rates on drugs that qualify under the 340B program.

Oral regimen of ledipasvir and sofosbuvir for hepatitis C virus shows improved treatment outcomes.

With new specialty pharmacies emerging and existing pharmacies evolving, accreditation has become more important.

Taurine may increase the remyelination effects of multiple sclerosis treatments.

Physically fit patients with coronary artery disease were nearly half as likely to die from cancer.

Top news of the day from across the health care landscape.

Nilotinib (Tasigna) label includes information for patients with chronic myeloid leukemia who may stop treatment after achieving remission.

GammaPod system can accurately deliver radiation therapy to breast tumors.

Significant novel drugs slated for review by the FDA in 2018.

New research suggests that treating a common parasitic infection may reduce HIV transmission rates.

A look back at the top articles of the year on Specialty Pharmacy Times.

Top news of the week from Specialty Pharmacy Times.

Grant Knowles, PharmD, vice president, Business Development, Ardon Health, discusses the role digital health may play in patient care.

A look at the most read drug approval articles of 2017 covered by Specialty Pharmacy Times.

Cigarette smoking played a role in 19% of cancers and 29% of cancer-related deaths in 2014.